Dr. Melvin Selinger, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3798 Janes Rd Ste 4, Arcata, CA 95521 Phone: 707-822-8395 Fax: 707-822-8637 |
News Archive
Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its board of directors approved a share repurchase program, effective immediately.
Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Eli Lilly and Company announced that it has made a charitable contribution to the Patient Advocate Foundation.
› Verified 6 days ago